Cargando…
Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer
Based on a few studies, heart failure patients with breast cancer were assessed to find potential biomarkers for doxorubicin-induced cardiotoxicity. However, key immune-related transcriptional markers linked to doxorubicin-induced cardiotoxicity in breast cancer patients have not been thoroughly inv...
Autores principales: | Xiong, Daiqin, Yang, Jianhua, Li, Dongfeng, Wang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514147/ https://www.ncbi.nlm.nih.gov/pubmed/37684436 http://dx.doi.org/10.1007/s12012-023-09806-5 |
Ejemplares similares
-
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
por: McSweeney, K. Melodi, et al.
Publicado: (2019) -
The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018) -
Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021) -
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
por: Todorova, Valentina K., et al.
Publicado: (2017)